Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
fda
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
3
×
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
drug price
immunotherapy
indiana blog main
indiana top stories
merck
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
abeona therapeutics
ac immune
acquisition
acute myeloid leukemia
affordable care act
agios pharmaceuticals
alirocuma
What
industry
3
×
bio
policy
roundup
american
arrival
based
best
biopharma
biotech
car
celgene
colleagues
companies
continue
crash
days
debate
exome
government
hasn’t
health
healthcare
hundreds
ipo
ipos
kind
life
market
medicine
momentum
nash
new
people
pharmaceutical
politicians
pressure
published
raised
ready
Language
unset
Current search:
industry
×
biotech
×
" san francisco top stories "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More